n/a (BHC.TO)

Toronto: BHC.TO · Echtzeitkurs · USD

9.65

+0.54 (5.93%)

Zum Schluss: Aug 18, 2026, 8:00 PM

5.93% (1D)

Keine Daten verfügbar

Geld	n/a
Marktkapitalisierung	3.61 Mrd
Umsatz (TTM)	n/a
Nettogewinn (TTM)	n/a
Beta	n/a
EPS (ttm)	-4.08
KGV (TTM)	n/a
Forward-KGV	n/a
KBV (TTM)	n/a
KUV (TTM)	n/a
Earnings Date	n/a

Brief	n/a
Volumen	838,286
Ø Vol. (20D)	625,334
Eröffnung	9.09
Vortagesschluss	9.11
Tagesspanne	9.09 - 9.76
52-Wk Range	6.10 - 11.08
Analyst	n/a
Kursziel	n/a
Dividenden	n/a
Ex-Dividenden-Datum	n/a

Über BHC.TO

A detailed description of the company is not yet available....

[Mehr lesen]

Branche n/a

Sektor n/a

IPO Datum n/a

Mitarbeiter n/a

Börse n/a

Tickersymbol BHC.TO

Vollständiges Unternehmensprofil

Gewinnüberraschung

hat die Quartalszahlen am Jul 29, 2026 veröffentlicht:

Umsatz von $2.85 Mrd verfehlt die Erwartungen um $0, mit 12.73% Wachstum im Jahresvergleich.

EPS von 1.26 übertrifft die Erwartungen um 0.25, mit 38.46% Wachstum im Jahresvergleich.

Nachrichten

vor 1 Woche · Motley Fool

Why Bausch Health Companies Stock Skyrocketed by Almost 40% Last Month

Much of this was due to a very well-received quarterly earnings report.

vor 2 Wochen · Insider Monkey

Bausch Health (BHC) Rockets 28% as Q2 Turnaround Fuels Recovery Outlook

Bausch Health (NYSE:BHC) climbed by 28.85 percent on Thursday to end at $6.03 apiece, after announcing a strong second quarter of the year that set the ground for the company’s profit recovery. In an ...

vor 2 Wochen · Zacks

BHC Q2 Earnings Beat Estimates on Salix and Solta Growth, '26 View Raised

BHC beats Q2 estimates as Salix, Solta Medical and Bausch + Lomb fuel growth, lifting 2026 revenue and EBITDA guidance after strong earnings.

vor 2 Wochen · Moby

Bausch Health Companies Inc. Q2 2026 Earnings Call Summary

Moby summary of Bausch Health Companies Inc.'s Q2 2026 earnings call

vor 2 Wochen · MarketBeat

Bausch Health Cos Q2 Earnings Call Highlights

Bausch Health Cos (NYSE:BHC) reported second-quarter results that management said extended its streak of revenue and adjusted EBITDA growth to 13 consecutive quarters, driven by performance in its Sal...

Seite 1 von 2